Literature DB >> 19022808

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

D E Furst1, E C Keystone, B Kirkham, A Kavanaugh, R Fleischmann, P Mease, F C Breedveld, J S Smolen, J R Kalden, G R Burmester, J Braun, P Emery, K Winthrop, B Bresnihan, F De Benedetti, T Dörner, A Gibofsky, M H Schiff, J Sieper, N Singer, P L C M Van Riel, M E Weinblatt, M H Weisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19022808     DOI： 10.1136/ard.2008.100834

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  30 in total

1.  Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis.

Authors:  S M Weiner; V Krenn; C Koelbel; H G Hoffmann; K Hinkeldey; D Ockert
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

Review 2.  microRNAs: critical regulators in Th17 cells and players in diseases.

Authors:  Bin Wei; Gang Pei
Journal:  Cell Mol Immunol       Date:  2010-04-05       Impact factor: 11.530

Review 3.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

Review 4.  [Anti-CD20 therapy in rheumatoid arthritis].

Authors:  P Roll; H-P Tony
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

5.  [Recommendations on therapy using interleukin-1beta-blocking agents].

Authors:  B Manger; M Gaubitz; H Michels
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

6.  Pulmonary tuberculosis and tuberculous arthritis of knee joint associated with rheumatoid arthritis treated with anti-tumor necrosis factor (TNF)-alpha medication: a case report.

Authors:  Selim Nalbant; Mustafa Özyurt; Murat Yıldırım; Mesih Kuskucu
Journal:  Rheumatol Int       Date:  2011-09-01       Impact factor: 2.631

Review 7.  Preventing and treating biologic-associated opportunistic infections.

Authors:  Kevin L Winthrop; Tom Chiller
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

Review 8.  Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes.

Authors:  Stewart J Levine; Sally E Wenzel
Journal:  Ann Intern Med       Date:  2010-02-16       Impact factor: 25.391

Review 9.  [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"].

Authors:  H Mei; T Dörner
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

Review 10.  How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?

Authors:  Diane L Kamen
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.